Clinical Trial Update: Phase II Trial of Allovectin-7® for Head and Neck Cancer [Phase 3]

View source ↗

Summary

This clinical trial update announces the completion of a Phase 3 study of Allovectin-7 for head and neck cancer, including squamous cell carcinoma of the oral c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Oropharyngeal Squamous Cell Carcinoma
• Squamous Cell Carcinoma of the Oral Cavity

Drugs mentioned

• Allovectin-7

Snippet

Sponsor: Vical | Conditions: Head and Neck Cancer, Squamous Cell Carcinoma of the Oral Cavity or Oropharynx | Phase 3 | Status: COMPLETED